Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring cell-labeling, the large size and short active lifetime of ultrasound contrast agents limit their longitudinal use. Here, 100 nm radius, clinically applicable, polymeric nanoparticles containing a liquid perfluorocarbon, which enhance ultrasound contrast during repeated ultrasound imaging over the course of at least 48 h, are described. The perfluorocarbon enables monitoring the nanoparticles with quantitative 19 F magnetic resonance imaging, making these particles effective multimodal imaging agents. Unlike typical core–shell perfluorocarbon-based ultrasound contrast agents, these nanoparticles have an atypical fractal internal structure. Th...
A versatile platform for the development of new ultrasound contrast agents is demonstrated through a...
Among medical imaging modalities available in the clinic, ultrasonography is the most convenient, in...
Imaging the enhanced permeation and retention effect by ultrasound is hindered by the large size of ...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring ...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring c...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring c...
\u3cp\u3e Ultrasound is the most commonly us...
Monitoring cell trafficking in vivo noninvasively is critical to improving cellular therapeutics, dr...
Perfluorocarbon nanoemulsions can deliver lipophilic therapeutic agents to solid tumors and simultan...
Perfluorocarbon-loaded nanoparticles are powerful theranostic agents, which are used in the therapy ...
Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vapori...
The use of polymeric nanoparticles (NPs) as therapeutics has been steadily increasing over past deca...
The use of polymeric nanoparticles (NPs) as therapeutics has been steadily increasing over past deca...
Perfluorocarbons hold great promise both as imaging agents, particularly for (19)F MRI, and in thera...
International audienceImaging the enhanced permeation and retention effect by ultrasound is hindered...
A versatile platform for the development of new ultrasound contrast agents is demonstrated through a...
Among medical imaging modalities available in the clinic, ultrasonography is the most convenient, in...
Imaging the enhanced permeation and retention effect by ultrasound is hindered by the large size of ...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring ...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring c...
Ultrasound is the most commonly used clinical imaging modality. However, in applications requiring c...
\u3cp\u3e Ultrasound is the most commonly us...
Monitoring cell trafficking in vivo noninvasively is critical to improving cellular therapeutics, dr...
Perfluorocarbon nanoemulsions can deliver lipophilic therapeutic agents to solid tumors and simultan...
Perfluorocarbon-loaded nanoparticles are powerful theranostic agents, which are used in the therapy ...
Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vapori...
The use of polymeric nanoparticles (NPs) as therapeutics has been steadily increasing over past deca...
The use of polymeric nanoparticles (NPs) as therapeutics has been steadily increasing over past deca...
Perfluorocarbons hold great promise both as imaging agents, particularly for (19)F MRI, and in thera...
International audienceImaging the enhanced permeation and retention effect by ultrasound is hindered...
A versatile platform for the development of new ultrasound contrast agents is demonstrated through a...
Among medical imaging modalities available in the clinic, ultrasonography is the most convenient, in...
Imaging the enhanced permeation and retention effect by ultrasound is hindered by the large size of ...